fda shortage tirzepatide update Eli Lilly's is off the FDA's drug list: Here's what it means FDA Announced Removal of Tirzepatide

Novo Nordisk has sued Eli Lilly in New Jersey federal court, alleging that national ads for Zepbound and Mounjaro rely on outdated clinical trial comparisons that omit the highest available doses of Wegovy and Ozempicnewer options that Novo says materially undermine Lillys claims of broad superiority

PloS Pathog

Various pathways in metabolism require zinc

Practical Techniques to Reduce Injection Site Swelling and Itching Rotating injection sites systematically prevents tissue fatigue and allows the dermis to recover between doses

In an interview, he argued that the mass marketing of compounded GLP-1s with slight variations from the FDA-approved version undermines the millions of dollars that pharmaceutical companies spend to ensure they make safe and effective products